Clinical Research Patient Recruitment Innovation: 2024 Year-End Review
By Chris Matheus
Clinical research patient recruitment innovation was a central focus for the Global Life Sciences Alliance (GLSA) throughout 2024. As the year comes to a close, we reflect on the progress made across our clinical research services network. These efforts improved trial efficiency, expanded patient access, and strengthened study outcomes.
We are proud to share the milestones that shaped our work over the past year and positioned GLSA for continued growth in 2025.
Expanding Clinical Research Patient Recruitment Impact
In 2024, the Global Life Sciences Alliance expanded its global footprint. Through a growing network of partners and alliances, we helped close gaps in patient identification and recruitment. This was especially impactful within underrepresented and diverse populations.
These efforts support a more inclusive approach to clinical research. They also help ensure trial outcomes better reflect the populations they are meant to serve.
One major achievement was GLSA’s inclusion in a pharmaceutical company’s request for information related to patient recruitment capabilities. This milestone validated our outreach and communication strategies. It also confirmed growing awareness of GLSA as a trusted resource.
Today, GLSA supports more than 100 Global Network Partners. We anticipate continued expansion in 2025.
Advancing Clinical Research Patient Recruitment Innovation
Throughout 2024, clinical research patient recruitment innovation played a key role in reducing enrollment timelines and improving retention. Innovation remained central to everything we built and launched.
By using data-driven strategies and emerging technologies, GLSA introduced new programs that streamlined recruitment while improving the patient experience. These programs focused on efficiency, accuracy, and engagement.
In particular, AI and machine learning tools supported inclusion and exclusion screening. These technologies reduced manual effort and helped trials enroll the right patients faster. Early results show meaningful improvements in both enrollment speed and retention.
Empowering the Next Generation of Science Leaders
Developing future leaders remained a priority in 2024. The GLSA Internship Program, led by co-founder Denise McNerney, provided hands-on experience and mentorship. Interns supported strategic initiatives, patient engagement, and operational projects.
We are also proud to recognize new GLSA team members. Aspen Buck, Clinical Solutions Manager, excelled while completing her degree in Healthcare Administration. Dylan Grierson also made key contributions by strengthening GLSA’s technology infrastructure.
Their efforts supported scalability and long-term growth.
Thought Leadership and Advocacy
GLSA leadership remained active in industry dialogue throughout 2024. Denise McNerney presented with the Healthcare Businesswomen’s Association and participated in a webinar focused on clinical trials and patient participation.
We also supported the launch of Women of Life Sciences, a LinkedIn group that meets monthly. The group focuses on networking, mentorship, and career development for women across the industry. These initiatives reflect GLSA’s commitment to diversity, inclusion, and patient empowerment.
Looking Ahead: The Future of Clinical Research Patient Recruitment
Looking ahead, GLSA will continue investing in clinical research patient recruitment innovation. As we move into 2025, our focus remains on growth, collaboration, and impact.
Key priorities include expanding technological capabilities, deepening patient engagement, and building new partnerships. We will also continue transforming our network into a true community. Shared expertise and collaboration will remain essential to solving complex clinical research challenges.
Gratitude and Closing Thoughts
This progress would not be possible without the trust of our Network Partners, clients, and team members. Denise and I are deeply grateful for your collaboration and support.
Together, we are shaping a future where clinical trials are more accessible and inclusive. We look forward to continuing this work in 2025 and beyond.
Warm regards,
Chris Matheus
Denise McNerney
Co-Founders, Global Life Sciences Alliance
About GLSA
Global Life Sciences Alliance (GLSA) connects biotechs, pharma, CROs, and clinical research sites with the right experts, advisors, and solutions to accelerate development and reduce risk. With a network of more than 200 trusted partners spanning pre-clinical and clinical research, GLSA offers flexible, cost-effective access to specialized expertise and services that support early-stage biotechs, mid-size pharma, and global pharmaceutical companies.
When you need trusted, global resources to accelerate your research, GLSA helps you scale smarter and move you forward with confidence.
To learn how GLSA can support your organization, connect with Denise McNerney or Chris Matheus for a conversation about your goals and challenges.